EPHX2 and fatty liver disease: In mice fed an HMD, sEH inhibition by TPPU ameliorated hepatic steatosis as shown by liver H&E staining and decreased hepatic triglycerides compared to controls, likely due to an increase in the expression of β-oxidation genes (Cpt1α, Acox1, and Mcad).